Die Beeinflussung der Elimination von Glycodiazin durch Leber- und Nierenfunktionsstörungen und durch eine Behandlung mit Phenylbutazon, Phenprocumarol und Doxycyclin
- 1 August 1970
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 6 (4) , 386-391
- https://doi.org/10.1007/bf01212070
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Zur Pharmakokinetik von Meprobamat bei chronischen Hepatopathien und ArzneimittelsuchtKlinische Wochenschrift, 1969
- PHENYLBUTAZONE AND ISONIAZID METABOLISM IN PATIENTS WITH LIVER DISEASE IN RELATION TO PREVIOUS DRUG THERAPYThe Lancet, 1968
- Rezidivierendes hypoglykämisches Koma infolge Abbaustörung von TolbutamidDeutsche Medizinische Wochenschrift (1946), 1968
- ACCUMULATION OF CHLORPROPAMIDE CAUSED BY DICOUMAROLActa Medica Scandinavica, 1968
- Effect of phenyramidol and bishydroxycoumarin on the metabolism of tolbutamide in human subjectsMetabolism, 1967
- DICOUMAROL-INDUCED DIPHENYLHYDANTOIN INTOXICATIONThe Lancet, 1966
- Protracted Tolbutamide-Induced HypoglycemiaArchives of internal medicine (1960), 1965
- Prolonged Tolbutamide-Induced HypoglycemiaPublished by American Medical Association (AMA) ,1963
- PERSISTENCE OF ANTIBIOTICS IN BLOOD OF PATIENTS WITH ACUTE RENAL FAILURE. II. CHLORAMPHENICOL AND ITS METABOLIC PRODUCTS IN THE BLOOD OF PATIENTS WITH SEVERE RENAL DISEASE OR HEPATIC CIRRHOSIS*†Journal of Clinical Investigation, 1959
- Metabolism of Drugs in Subjects with Laennec’s CirrhosisPharmacology, 1959